Globus Medical (NYSE: GMED) and Sunshine Heart (NASDAQ:SSH) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitabiliy, valuation, risk, institutional ownership, earnings, analyst recommendations and dividends.
Profitability
This table compares Globus Medical and Sunshine Heart’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Globus Medical | 18.09% | 14.15% | 12.73% |
| Sunshine Heart | N/A | -302.32% | -126.49% |
Analyst Recommendations
This is a breakdown of recent ratings and recommmendations for Globus Medical and Sunshine Heart, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Globus Medical | 1 | 5 | 3 | 0 | 2.22 |
| Sunshine Heart | 0 | 0 | 0 | 0 | N/A |
Globus Medical presently has a consensus target price of $28.71, suggesting a potential downside of 7.49%. Sunshine Heart has a consensus target price of $0.23, suggesting a potential downside of 62.47%. Given Globus Medical’s higher probable upside, research analysts clearly believe Globus Medical is more favorable than Sunshine Heart.
Institutional & Insider Ownership
69.4% of Globus Medical shares are owned by institutional investors. 28.2% of Globus Medical shares are owned by insiders. Comparatively, 3.0% of Sunshine Heart shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Volatility & Risk
Globus Medical has a beta of 0.62, meaning that its share price is 38% less volatile than the S&P 500. Comparatively, Sunshine Heart has a beta of 2.59, meaning that its share price is 159% more volatile than the S&P 500.
Earnings & Valuation
This table compares Globus Medical and Sunshine Heart’s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | EBITDA | Earnings Per Share | Price/Earnings Ratio | |
| Globus Medical | $580.54 million | 5.14 | $205.33 million | $1.09 | 28.48 |
| Sunshine Heart | N/A | N/A | N/A | ($33.63) | -0.02 |
Globus Medical has higher revenue and earnings than Sunshine Heart. Sunshine Heart is trading at a lower price-to-earnings ratio than Globus Medical, indicating that it is currently the more affordable of the two stocks.
Summary
Globus Medical beats Sunshine Heart on 9 of the 10 factors compared between the two stocks.
About Globus Medical
Globus Medical, Inc. (Globus) is a medical device company focused on the design, development and commercialization of musculoskeletal implants that promote healing in patients with spine disorders. The Company is focused on implants that promote healing in patients with spine disorders. The Company’s products fall into one of two categories: Innovative Fusion or Disruptive Technologies. The Company sells its products through exclusive sales force in the United States, as well as within North, Central & South America, Europe, Asia, Africa and Australia. The sales force consists of direct sales representatives and distributor sales representatives employed by exclusive independent distributors.
Receive News & Ratings for Globus Medical Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globus Medical Inc and related companies with MarketBeat.com's FREE daily email newsletter.
